X
CLOV icon

Xponance’s Clover Health Investments CLOV Stock Holding History

Xponance’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
41,415
+4,500
+12% +$15.3K ﹤0.01% 1571
2026
Q1 		$65K Buy
36,915
+4,900
+15% +$10.6K ﹤0.01% 1612
2025
Q4 		$75.2K Buy
32,015
+599
+2% +$1.64K ﹤0.01% 1492
2025
Q3 		$96.1K Buy
31,416
+274
+0.9% +$783 ﹤0.01% 1446
2025
Q2 		$86.9K Buy
+31,142
New +$102K ﹤0.01% 1423
2023
Q2 		– Sell
-22,047
Closed -$18.6K – 1265
2023
Q1 		$18.6K Hold
22,047
– – ﹤0.01% 1218
2022
Q4 		$20.5K Buy
22,047
+219
+1% +$292 ﹤0.01% 1216
2022
Q3 		$37K Buy
21,828
+1,266
+6% +$3.32K ﹤0.01% 1159
2022
Q2 		$44K Buy
+20,562
New +$54.6K ﹤0.01% 1163

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Xponance's CLOV Position: Q2 2026 in Review

Xponance increased its Clover Health Investments (CLOV) stake by 12% in Q2 2026, buying an estimated $15.3K and bringing the position to 41,415 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #1571.

Xponance first reported a position in CLOV in Q2 2022 and has held it in 9 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Xponance held 41,415 shares of Clover Health Investments worth $217K as of Q2 2026.
  • Xponance bought 4,500 Clover Health Investments shares in Q2 2026, an estimated $15.3K.
  • Clover Health Investments made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1571 holding.
  • Xponance first reported a position in Clover Health Investments in Q2 2022 and has held it in 9 quarters since.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.